| CAS ID: | 41859-67-0 |
| Molecular Formula: | C19H20ClNO4 |
| Molecular Weight: | 361.8 g/mol |
| Monoisotopic Mass: | 361.1081 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | BEZALIP | BEZAGEN XL | LIPAROL XL | BM 15.075 | BEZALIP-MONO | FIBRAZATE XL | BEZAFIBRATE | ZIMBACOL XL |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 18513333 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | HSCs activation | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT02937012 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Recruiting |
| First Received | October 18, 2016 | Last Verified | April 23, 2018 |
| Sponsor | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | ||
| PubChem: | 39042 |
| ChEMBL: | CHEMBL264374 |